Facebook Twitter instagram Youtube
newsletter-september-2020

THE EXCHANGE | Newsletter September-2020

IN THE NEWS:

 

Medanta has been voted as the Best Private Hospital in India

 

Best-Hospital-India

Testimony to the world-class healthcare it provides, Medanta has been acknowledged as the best private healthcare provider in India in the World’s Best Hospitals 2020 survey by Newsweek in partnership with Statista Inc.

Conducted across hospitals in 21 countries, the survey is based on recommendations from medical professionals, results from patient surveys and key medical performance indicators.

Read More

 

 

PIONEERING HEALTHCARE

 

Medanta Treats Aneurysm <2mm Size Pioneers Use of Mini Flow Diverter

 

Medanta - Gurugram became the first hospital in India to treat aneurysm not amenable to routine surgical clipping and endovascular coiling by using mini flow diverter, a new breakthrough device used to treat very small (<2mm) distal brain aneurysms. The procedure was done successfully using minimally invasive endovascular technique without opening the skull. Until now, treating such aneurysms using surgical clipping and available endovascular devices was a challenge with relatively higher risk.

Read More

 

 

OUR EXPERTISE:

 

Knowledge Byte on Anatomical and Reverse Shoulder Replacement Procedure

 

Osteo-arthritis of the shoulder joint is a progressive disorder characterized by damage to the articular cartilage of humeral head and/or glenoid. It can lead to debilitating functional limitations, compromising the individual’s quality of life. Shoulder Replacement is the only solution for such patients. Reverse Shoulder Replacement has emerged as the preferred technique for dealing with longstanding cases of arthritis/ tendon damage/ fractures or complications arising out of previous treatments or neglect.

Read More
 
 
 
 

PROSTATE CANCER AWARENESS MONTH:

 

Everything you should know about Prostate Cancer

 

Prostate-Cancer

Globally, prostate cancer is the second most frequently diagnosed cancer and the fifth most common cause of cancer death among men. Its incidence has particularly increased after 1991 with advent of prostate specific antigen (PSA) screening in men over 50 years of age. Most cases present after age of 60 years. Risk factors include older age, family history, race (caucasians).

Prostate cancer rarely causes symptoms at an early stage. The presence of symptoms suggests locally advanced or metastatic disease.

Read More
Medanta Medical Team
Back to top